Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
6-month placebo-controlled CPC mouthrinse study in gingivitis
NL-OMON25365Recruiting
- Sponsor
- Dentaid
- Start
- Jun 2009
- Modality
- Small Molecules, Conventional Liposomes → Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, double-blind trial of cetylpyridinium chloride in gingivitis (2 arms), sponsored by Dentaid. Primary endpoint: Plaque score. Started Jun 2009; status: recruiting.
02
Drugs
cetylpyridinium chloride
03
Conditions
gingivitis
Beyond the preview
Go deeper on NL-OMON25365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25365.